INTERNATIONAL SOCIETY OF VACCINES … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

LINDA KLAVINSKIS

Phone

5088561179

Tax Period

2023-01-01 to 2023-12-31

INTERNATIONAL SOCIETY OF VACCINES INC, founded in 2010, is a small nonprofit in the Community Improvement sector that reported $559K in total revenue in fiscal year 2023. Revenue surged 123% from the prior year, signaling strong growth momentum. Expenses of $495K left a modest 11% surplus.

Mission

PROMOTE SCIENTIFIC RESEARCH AND DEVELOPMENT OF VACCINES TO PREVENT AND CONTROL INFECTIOUS AND NON-INFECTIOUS DISEASES IN HUMANS AND ANIMALS

Program Service Accomplishments

Program 1

Expenses: $373,154 Revenue: $471,969

ANNUAL CONGRESS - THE ISV ANNUAL CONGRESS IS THE WORLD'S LARGEST SCIENTIFIC NONPROFIT CONFERENCE IN THE FIELD OF VACCINES AND COVERS A BROAD RANGE OF TOPICS RELATED TO VACCINES AND IMMUNOTHERAPIES...

ANNUAL CONGRESS - THE ISV ANNUAL CONGRESS IS THE WORLD'S LARGEST SCIENTIFIC NONPROFIT CONFERENCE IN THE FIELD OF VACCINES AND COVERS A BROAD RANGE OF TOPICS RELATED TO VACCINES AND IMMUNOTHERAPIES, BRINGING TOGETHER INDIVIDUALS FROM ALL SECTORS OF THE GLOBAL VACCINE COMMUNITY TO HEAR ABOUT THE LATEST ADVANCES IN THE FIELD, DISCUSS CHALLENGES AND OPPORTUNITIES, AND NETWORK.

Program 2

Revenue: $22,035

MEMBERSHIP - AS A PROFESSIONAL SCIENTIFIC SOCIETY, ISV ASSESSES MEMBERSHIP DUES. IN ADDITION TO PROVIDING MEMBERS THE OPPORTUNITY TO INTERACT WITH SCIENTIFIC COLLEAGUES AT ISV'S CONGRESS (WHERE...

MEMBERSHIP - AS A PROFESSIONAL SCIENTIFIC SOCIETY, ISV ASSESSES MEMBERSHIP DUES. IN ADDITION TO PROVIDING MEMBERS THE OPPORTUNITY TO INTERACT WITH SCIENTIFIC COLLEAGUES AT ISV'S CONGRESS (WHERE MEMBERS PAY A REDUCED REGISTRATION FEE), MEMBERS RECEIVE THE SOCIETY'S MEMBERS-ONLY NEWSLETTER, HAVE THE OPPORTUNITY TO PARTICIPATE IN SOCIETY COMMITTEES THAT FOCUS ON EDUCATION AND MENTORING OF TRAINEES AND JUNIOR SCIENTISTS, ORGANIZE ON-LINE AND REGIONAL SYMPOSIA, AND HAVE INCREASED OPPORTUNITIES TO ESTABLISH SCIENTIFIC COLLABORATIONS THROUGH PARTICIPATION IN THE SOCIETY'S ACTIVITIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $62,961

Program Service Revenue $494,004

Investment Income $2,331

Other Revenue $0

TOTAL REVENUE $559,296

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $373,154

Other Expenses $495,186

TOTAL EXPENSES $495,186

Year-over-Year Comparison

	2023	2022	Change
Revenue	$559,296	$250,591	+1.2%
Expenses	$495,186	$266,569	+0.9%
Net Income	$64,110	$-15,978	-5.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DENISE DOOLAN	PRESIDENT	1.00	Officer Director	$0	$0	$0
JEFFREY ULMER	TREASURER	1.00	Officer Director	$0	$0	$0
XAVIER SAELENS	SECRETARY	1.00	Officer Director	$0	$0	$0
LINDA KLAVINSKIS	PRESIDENT-ELECT	5.00	Officer Director	$0	$0	$0
TED ROSS	PRESIDENT-EMERITUS	1.00	Officer Director	$0	$0	$0
BRUNO CORREIA	DIRECTOR	1.00	Director	$0	$0	$0
MANON COX	DIRECTOR	1.00	Director	$0	$0	$0
LARS FRELIN	DIRECTOR	1.00	Director	$0	$0	$0
ANKE HUCKRIEDE	DIRECTOR	1.00	Director	$0	$0	$0
MARIA ISSAGOULIANTIS	DIRECTOR	1.00	Director	$0	$0	$0
MARGARET LIU	DIRECTOR	1.00	Director	$0	$0	$0
SHAN LU	DIRECTOR	1.00	Director	$0	$0	$0
LENNY MOISE	DIRECTOR	1.00	Director	$0	$0	$0
JOON HAENG RHEE	DIRECTOR	1.00	Director	$0	$0	$0
DAVID WEINER	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$559,296	$495,186	$350,094	$64,110
2023	No data	No data	No data	No data
2022	$250,591	$266,569	$441,984	$-15,978
2021	$137,365	$79,308	$301,962	$58,057
2020	$49,175	$75,176	$243,905	$-26,001
2019	$393,338	$295,017	$269,906	$98,321
2018	$271,553	$324,816	$171,585	$-53,263

INTERNATIONAL SOCIETY OF VACCINES INC